Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

iRhythm Technologies Inc.

www.irhythmtech.com

Latest From iRhythm Technologies Inc.

Verily And iRhythm Agree To Collaborate On Atrial Fibrillation

Verily Life Sciences and iRhythm Technologies have agreed to co-develop technology for screening, diagnosing and managing patients with atrial fibrillation, combining iRhythm’s artificial intelligence system for diagnosing arrhythmias with Verily’s health data analytics technology.

Deals Artificial Intelligence

Vagus Nerve Stimulation Ear Clip Reduces Atrial Fibrillation In Sham-Controlled Trial

Results of the TREAT AF trial showed low-level transcutaneous electrical stimulation of the auricular branch of the vagus nerve through the tragus of the patient’s ear reduced atrial fibrillation burden over six months.

Clinical Trials Innovation

ACC Results Recap Part II: CardioMEMS Post-Approval Trial Shows Monitoring Reduces Heart-Failure Hospitalizations; Medtronic’s Tyrx Envelope Reduces Infections

Medtech Insight's Results Recap is a regular feature covering the major device trial results compiled by MedDeviceTracker. This is the second of three Results Recaps covering trial data presented at the American College of Cardiology Scientific Sessions in New Orleans, March 16-18, including clinical trial data on devices from Abbott Laboratories, Medtronic, Medi-Lynx, and iRhythm. See Part 1 of our ACC Results Recap for more on the groundbreaking trials of transcatheter aortic valve replacement in low-risk patients and the Apple Heart study of Apple Watch's ability to track atrial fibrillation.

Tracking Trials Clinical Trials

iRhythm Builds Momentum Following Large Trial Of AI Approach To ECG Analysis

Results from a study of more than 91,000 ECG records collected with iRhythm’s Zio ambulatory continuous cardiac monitoring device that demonstrates the successful application of artificial intelligence to ECGs gives the 12-year-old company confidence that it will be profitable very soon.

Commercial Companies
See All

Company Information

  • Industry
  • Medical Devices
    • Diagnostic Equipment & Supplies
    • Monitoring Equipment & Devices
  • Therapeutic Areas
  • Cardiovascular
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • iRhythm Technologies Inc.
  • Senior Management
  • Kevin M King, Pres. & CEO
    Matthew C Garrett, CFO
    David A Vort, EVP, Sales
    Mark J Day, PhD, EVP, R&D
    Marga Ortigas-Wedekind, EVP, Mktg.
    Derrick Sung, PhD, EVP, Strategy & Corp. Dev.
  • Contact Info
  • iRhythm Technologies Inc.
    Phone: (415) 632-5700
    650 Townsend St., Ste. 380
    San Francisco, CA 94103
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register